1. Home
  2. OTTR vs CRSP Comparison

OTTR vs CRSP Comparison

Compare OTTR & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OTTR
  • CRSP
  • Stock Information
  • Founded
  • OTTR 1907
  • CRSP 2013
  • Country
  • OTTR United States
  • CRSP Switzerland
  • Employees
  • OTTR N/A
  • CRSP N/A
  • Industry
  • OTTR Electric Utilities: Central
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • OTTR Utilities
  • CRSP Health Care
  • Exchange
  • OTTR Nasdaq
  • CRSP Nasdaq
  • Market Cap
  • OTTR 3.5B
  • CRSP 3.4B
  • IPO Year
  • OTTR N/A
  • CRSP 2016
  • Fundamental
  • Price
  • OTTR $78.96
  • CRSP $37.77
  • Analyst Decision
  • OTTR
  • CRSP Buy
  • Analyst Count
  • OTTR 0
  • CRSP 19
  • Target Price
  • OTTR N/A
  • CRSP $74.35
  • AVG Volume (30 Days)
  • OTTR 337.4K
  • CRSP 2.4M
  • Earning Date
  • OTTR 05-05-2025
  • CRSP 05-07-2025
  • Dividend Yield
  • OTTR 2.65%
  • CRSP N/A
  • EPS Growth
  • OTTR 2.43
  • CRSP N/A
  • EPS
  • OTTR 7.17
  • CRSP N/A
  • Revenue
  • OTTR $1,330,548,000.00
  • CRSP $37,314,000.00
  • Revenue This Year
  • OTTR $2.59
  • CRSP $51.35
  • Revenue Next Year
  • OTTR $4.32
  • CRSP $282.16
  • P/E Ratio
  • OTTR $11.01
  • CRSP N/A
  • Revenue Growth
  • OTTR N/A
  • CRSP N/A
  • 52 Week Low
  • OTTR $71.66
  • CRSP $30.04
  • 52 Week High
  • OTTR $100.84
  • CRSP $67.88
  • Technical
  • Relative Strength Index (RSI)
  • OTTR 48.29
  • CRSP 49.46
  • Support Level
  • OTTR $77.93
  • CRSP $36.74
  • Resistance Level
  • OTTR $80.71
  • CRSP $40.13
  • Average True Range (ATR)
  • OTTR 2.69
  • CRSP 2.67
  • MACD
  • OTTR 0.04
  • CRSP 0.72
  • Stochastic Oscillator
  • OTTR 70.99
  • CRSP 76.62

About OTTR Otter Tail Corporation

Otter Tail Corp is a U.S. energy company that operates in the electric (produces and sells electricity), manufacturing (fabricates metal components), and plastics segments (pipes for water uses). The company conducts its operations and acquires the majority of its revenue in the U.S. in the states of Minnesota, South Dakota, and North Dakota. The majority of the company's revenue is derived from the Electric segment and commercial customers, although it generates revenue from residential and industrial customers, as well.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: